EE459 Cost-Effectiveness Analysis of Adjuvant Alectinib Compared to Platinum-Based Adjuvant Chemotherapy in Patients With Resectable ALK-Positive NSCLC in Italy
Abstract
Authors
M Paoletti V Scansetti D Cazzato A Marcellusi M Belfiore J Isoko M Pacifici LD Cortinovis G Veronesi